HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

ICOR 2016

Veronica James, Speaker at Cancer Conferences
Keynote Presentation
Veronica James, Australian National University, Australia

Using fibre diffraction, cancers can be diagnosed as soon as they start to grow, so they can be diagnosed very early. For most men, therefore, prostate cancers can be diagnosed as low grade in their twenties. At this stage, these cancers can be removed by chemotherapy and radiati [....] » Read More

Jurgen Arnhold, Speaker at Cancer Conferences
Keynote Presentation
Jurgen Arnhold, German Society for Urology, Germany

Presentation will discuss the following concepts: · Fundamentals of low level laser therapy · Interstitial and intra-articular laser therapy · Intravenous (systemic) laser therapy · Photodynamic tumor therapy · Medical effects of laser ligh [....] » Read More

Angel Arnaout, Speaker at Cancer Congress
Keynote Presentation
Angel Arnaout, University of Ottawa, Canada

Every year, countless women will be diagnosed and treated for breast cancer, most of whom will require surgery. A clean margin around the cancer site is the only prognostic factor that a surgeon can control in order to reduce local recurrence. Having an accurate method of assessi [....] » Read More

M Amin Nezami, Speaker at Cancer Congress
Oral Presentation
M Amin Nezami, Pacific Medical Center of Hope, United States

This abstract discusses epigenetic regulations of hypoxia and its genomic transcription. The aberrancies in DNA methylation of several genes are crucial for vasculogenesis. By regulating this epigenetic mechanism, using a novel muti-targeted epigenetic therapy (MTET), we showed i [....] » Read More

Jayashree Paknikar, Speaker at Oncology Conferences
Oral Presentation
Jayashree Paknikar, Creighton University School of Medicine, United States

Ovarian Cancer is the second most common gynecologic malignancy and the most common cause of death amongst women with gynecologic cancer. Worldwide 239,000 new cases of were diagnosed in 2012. In the US alone, 22,000 new cases of ovarian are diagnosed annually and 14,000 women di [....] » Read More

Barbara Wood, Speaker at Oncology Conference
Oral Presentation
Barbara Wood, Boob Buddies Inc, Australia

There appears to be general consensus in available literature that care for patients with life-threatening illnesses is suboptimal (Fitzsimons et al., 2007), and that research addressing the need of this population is limited (Wilson et al., 2007). One such need which does not ap [....] » Read More

Khushwinder Kaur, Speaker at Cancer Conferences
Oral Presentation
Khushwinder Kaur, Panjab University, India

Dietary phytochemicals play an important role in cancer management because they have been found to have the potential to delay or impede carcinogenesis process. However, they suffer from poor solubility, rapid degradation, leading to poor absorption by the human body. Hence, on [....] » Read More

Razia Bano, Speaker at Cancer Conferences
Oral Presentation
Razia Bano, Shaukat Khanum Memorial Cancer Hospital & Research Centre Lahore, Pakistan

Background: Breast cancer diagnosed at younger age has aggressive biology being triple negative and high grade and associated with poor prognosis. Patients and Methods: Retrospectively data of 121 patients age 30 years or younger registered during the year 2008 was reviewed. Dat [....] » Read More

Alessandro Bacuzzi, Speaker at Cancer conferences
Oral Presentation
Alessandro Bacuzzi, Varese University Hospital, Italy

The cooperative approach between physicians during cancer patients treatment is actually a medical cornerstone. New developments centered on interventional radiology have transformed the oncological outcome of not candidate surgical patients. As proposed by Executive Council of t [....] » Read More

Chinedu Simeon Aruah, Speaker at Cancer Congress
Oral Presentation
Chinedu Simeon Aruah, National Hospital Abuja, Nigeria

Introduction: Anaemia is one of the predisposing factors to poor patient outcome in cancer treatment and more than 50% of cancer patients will receive radiotherapy in the course of their treatment. It has been difficult to establish global or National benchmark on the baseline ha [....] » Read More

Mohammed Al Zahrani, Speaker at Cancer Congress
Oral Presentation
Mohammed Al Zahrani, KSAU-HS college of pharmacy, Saudi Arabia

Background: Stem cell transplantation procedure is considered nowadays an important lifesaving therapy for variety of fatal blood diseases. One of the main challenging facing stem cells transplantation therapies is to find a perfect match; that make many national and internationa [....] » Read More

Muna Baslaim, Speaker at  Oncology Conferences
Oral Presentation
Muna Baslaim, King Fahd General Hospital, Saudi Arabia

Background: The behavior of some of the rare types of breast cancer is not well understood. Objective: To study the presentation, pathology and outcome of some of the rare types of breast cancer. Methods: Rare types of breast cancer cases seen at King Fahd Hospital from 2008 til [....] » Read More

Kerim Aslan, Speaker at  Oncology Conferences
Oral Presentation
Kerim Aslan, Ondokuz Mayis University, Turkey

Objective: Low grade and atypical/anaplastic (high grade) meningiomas may look similar in conventional MRI. Since the surgery or treatment plan, tumor recurrence and treatment results of these two tumors are different from each other, it is important to differentiate between them [....] » Read More

Zulfiya Shafigullina, Speaker at  Oncology Conferences
Oral Presentation
Zulfiya Shafigullina, North-Western State Medical University named after I.I Mechnikov, Russian Federation

Adrenocortical carcinoma (ACC) is a malignant tumor, which can occur at any age. The prevalence of ACC in population is 0.5-2 cases per 1,000,000 people per year; the incidence of ACC in patients with adrenal incidentalomasis 1.2- 12%. By the revealing adrenal tumor, it is necess [....] » Read More

Mustafa Pehlivan, Speaker at  Oncology Conferences
Oral Presentation
Mustafa Pehlivan, Cyprus International University, Cyprus

The purpose of this paper is to introduce a newly discovered anti androgen compound (pentabromo-dicyclohexane) which has a very high potential of being used as a medicine to treat prostate cancer and reduce the symptoms of cancer. The molecule has been discovered based on the Tar [....] » Read More

Mahmoud Rezk, Speaker at Cancer Congress
Oral Presentation
Mahmoud Rezk, NCI Cairo University, Egypt

Purpose: To assess the diagnostic performance of WB-DWIBS compared to FDG-PET-CT in assessment of breast cancer patients. Method and Materials: 50 patients with pathologically proven breast cancer underwent both F-18-FDG PET-CT and WBMRI/DWIBS. The sequences acquired are whole b [....] » Read More

Christian Ntizimira, Speaker at  Cancer Congress
Oral Presentation
Christian Ntizimira, Rwanda Palliative Care & Hospice Organisation (RPCHO), Rwanda

Multi-disciplinary palliative care for patients with any Cancer is rarely integrated into the public healthcare system at all levels in Africa. An example of Rwanda, we have developed palliative care services in a district general hospital and linked these services to home care. [....] » Read More

Christian Ntizimira, Speaker at  Cancer Congress
Oral Presentation
Christian Ntizimira, Rwanda Palliative Care & Hospice Organisation (RPCHO), Rwanda

Multi-disciplinary palliative care for patients with any Cancer is rarely integrated into the public healthcare system at all levels in Africa. An example of Rwanda, we have developed palliative care services in a district general hospital and linked these services to home care. [....] » Read More

Subhash Paknikar, Speaker at Cancer Congress
Keynote Presentation
Subhash Paknikar, Creighton University School of Medicine, United States

Radium-223 dichloride (Ra-223) is indicated in patients with castration resistant prostate cancer with symptomatic bone metastasis but without any known visceral metastatic disease.Radium-223 dichloride primarily prolongs survival, improves quality of life (proven by ECOG score), [....] » Read More

Xiufen Zheng, Speaker at Cancer Conferences
Keynote Presentation
Xiufen Zheng, University of Western Ontario, Canada

Dendritic cell (DC)-based therapies have been introduced to treat cancer. In spite of pre-clinical promise, response in patients has been disappointing. Immunosuppressive molecules produced by tumour or host cells appear to be at least partially responsible for the poor outcome. [....] » Read More

Angel Arnaout, Speaker at Cancer Congress
Oral Presentation
Angel Arnaout, University of Ottawa, Canada

The enormous number of new biological agents aligned with the large investment that is required for their registration is a major challenge for clinical oncology and the pharmaceutical industry. The neoadjuvant scenario is seen as a means of prioritizing drugs for clinical develo [....] » Read More

Madiha Rehman, Speaker at Cancer Conferences
Oral Presentation
Madiha Rehman, Armed Forces Institute of Pathology, Pakistan

Background: Triple negative breast cancer (TNBC) is generally associated with poor outcome, high rates of local recurrence and metastatic disease. Objective: To study the presentation, pathology and prognostic parameters in triple negative breast cancer Patient and methods: 100 [....] » Read More

Debjani Dasgupta, Speaker at Oncology Conferences
Oral Presentation
Debjani Dasgupta, D. Y. Patil University, India

Use of herbal medicines alone and in combination with conventional anticancer agents has increased remarkably in cancer patients. However, lack of scientific evidence has limited the use of these cocktails. Thus it is necessary to evaluate the effect of these combinations alone a [....] » Read More

Oliver Szasz, Speaker at Oncology Conferences
Oral Presentation
Oliver Szasz, St.Istvan University, Hungary

Background: Hyperthermia in oncology is a tool of destroying the malignant cells on thermal way. The action could be a direct thermal toxicity for cells and/or boost other therapies to eliminate cancer cells. The definite aim of curative hyperthermia is to be selective on the mal [....] » Read More

Nadia Shirazi, Speaker at 
Oncology Conference
Oral Presentation
Nadia Shirazi, Himalayan Institute of Medical Sciences, India

This presentation will tabulate all the cases of squamous cell carcinoma irresepective of their site of origin that were operated in a tertiary referral centre of North India. Tumors were histomorphologically divided into low and high grades of tumor associated tissue eosinophili [....] » Read More

Ravi Kiran Pothamsetty, Speaker at Cancer Congress
Oral Presentation
Ravi Kiran Pothamsetty, Kamala Nehru Memorial Hospital, RCC, India

Background: Oropharyngeal cancer is primarily a disease of elderly, frequently seen in patients older than age 45. A group of oropharyngeal cancer patients has been considered in our study because of rising trends of its incidence due to tobacco abuse even in youngsters. Aim: To [....] » Read More

Rebekka Manohar Marri, Speaker at Cancer Conferences
Oral Presentation
Rebekka Manohar Marri, Tata Memorial Centre, India

Introduction: Vesicovaginal Fistula (VVF) is an abnormal opening between the urinary bladder and vagina that result in continuous, involuntary dribbling (incontinence) of urine from the vagina. It is a common complication reported in advance gynaecological cancer conditions. Radi [....] » Read More

Kofi Adesi Kyei, Speaker at Cancer Conferences
Oral Presentation
Kofi Adesi Kyei, University of Ghana, Ghana

The feeling of fear, distress and uneasiness of an imminent endangerment is described as anxiety and in the setting of the proposed study, anxiety goes down to the principal feeling among patients undergoing various degree of cancer treatment. Depression is the level of symptoms [....] » Read More

Borislav D Dimitrov, Speaker at Cancer Congress
Oral Presentation
Borislav D Dimitrov, University of Southampton, United Kingdom

Background: Physical activity (PA) monitors have been validated as an objective measure of physical activity levels (PAL) in several patient cohorts; however to our knowledge they have never been used to evaluate PAL in people with newlydiagnosed cancer. The aim of this pilot stu [....] » Read More

Shreeya Pabi, Speaker at  Oncology Conferences
Oral Presentation
Shreeya Pabi, Vydehi Institute of Medical Sciences and Research Center, India

Background: Brachytherapy plays a pivotal role as a part of the cervical cancer management for its ability to deliver high dose to the tumour while reducing the dose to the surrounding critical organs. Over the last few years, the use of 3D image based brachytherapy has been revo [....] » Read More

Virendra Vyas, Speaker at  Oncology Conferences
Oral Presentation
Virendra Vyas, Mahatma Gandhi Institute of Medical Sciences, India

Introduction: Cervical cancer is still major cancer burden in Indian women and it has major impact on their lives .Though the incidence of cervical cancer is decreasing in the developing countries and urban India with the help of proper screening and vaccination, the situation am [....] » Read More

Malihea Khaleghian, Speaker at 

Oncology Conference
Oral Presentation
Malihea Khaleghian, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: During the past decades, the incidence rate of stomach cancer in western countries has shown a great decrease, while it is still the most common cancer among men in Iran. The MYC proto-oncogene, which is located at 8q24.1, regulates 15% of genes and is activated in [....] » Read More

Malihea Khaleghian, Speaker at 

Oncology Conference
Oral Presentation
Malihea Khaleghian, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Introduction: During the past decades, the incidence rate of stomach cancer in western countries has shown a great decrease, while it is still the most common cancer among men in Iran. The MYC proto-oncogene, which is located at 8q24.1, regulates 15% of genes and is activated in [....] » Read More

Shaista Suhail , Speaker at Cancer Congress 2016
Oral Presentation
Shaista Suhail , D.B.P.G.C, Raebareli, India

Presently, cancer one of the most prevalent types of disease is a growing health problem around the world and is the leading cause of death. According to a recent report of W.H.O from a total of 58 million deaths worldwide, cancer accounted for 13%. Worldwide, there are now more [....] » Read More

Orynbassar Karapina, Speaker at Cancer Conferences
Poster Presentation
Orynbassar Karapina, Nazarbayev University, Kazakhstan

Background: Cancer is a serious group of disease that could be resulted from different genetic alterations at molecular level, which could be followed by the unbalancing processes like high cell growth, proliferation, no programmed cell death, high affinity to invade through the [....] » Read More

Maxim Rossmann, Speaker at Cancer Conferences
Poster Presentation
Maxim Rossmann, University of Cambridge, United Kingdom

Prostate cancer is the most common malignancy in men. Worldwide, 1 of 7 men will be diagnosed with the disease at some time in their lives. Population-based non-invasive screening tests for prostate cancer did not definitively prove to affect disease-specific mortality and genera [....] » Read More

Yoshiaki Omura, Speaker at Cancer Congress
Poster Presentation
Yoshiaki Omura, New York Medical College, United States

We found optimal dose of Vitamin D3 400 I.U. has a safe & significant anti-cancer effect without side effects. However, widely used vitamin D3 of 2000~5000 or even higher dose has cancer-promoting effects. In the patient with liver & kidney problem, Vitamin D3 could not b [....] » Read More

Nima Kasraie, Speaker at Cancer Conferences
Poster Presentation
Nima Kasraie, Children’s Mercy Hospital, United States

The nature of pediatric imaging poses unique challenges and risks that continue to evoke attention and scrutiny in public circles. Effective communication of radiation risk is an essential core practice and competency for radiologists, technologists, and staff involved with pedia [....] » Read More

Michael Weber, Speaker at  Oncology Conferences
Workshop
Michael Weber, Weber medical Laser Treatment and Research Centers, Germany

In this workshop all new methods of photodynamic laser therapy will be presented. The mechanism of photodynamic laser therapy and the different photosensitizers and lasers for stimulation will be demonstrated and explained in detail. The newest Endolaser device for local, intrave [....] » Read More

Maciej Harat, Speaker at Cancer Congress
Oral Presentation
Maciej Harat, The Franciszek Lukaszczyk Oncology Center, Poland

Comparison of pre-treatment MRI and dual time-point 18F-fluoroethylthyrosine-PET (FET-PET)-based target volumes with patterns of primary glioblastoma multiforme failure following radiotherapy with temozolomide is done. Established that FET-based tumor volumes measured 10 minutes [....] » Read More

Francesco Arrigoni, Speaker at Cancer Congress
Oral Presentation
Francesco Arrigoni, University of L’Aquila, Italy

I nterventional Radiology (IR), thanks to the development in technological and Knowledge skills, has achieved a firstline role in the treatment of bone lesions. In particular, a large range of benign and malignant lesions can be treated: not only the well known ablations of osteo [....] » Read More

Quratulain Badar, Speaker at  Oncology Conferences
Oral Presentation
Quratulain Badar, Ziauddin University, Pakistan

Background: Adaptive radiotherapy (ART) is defined as all processes leading to the modification of a treatment plan due to treatment response or change in patient contour secondary to weight loss observed during the course of a treatment. Because of the greater conformity of 3-DC [....] » Read More

Alisher Agzamov, Speaker at  Oncology Conferences
Oral Presentation
Alisher Agzamov, Kuwait Cancer Control Center (KCCC), Kuwait

BACKGROUND: Robotic telepresence has been used for outsourcing of healthcare services for more than a decade; however, its use within a Surgical and Medical Oncology ICU is not yet widespread. Intensive care unit (ICU) robots can be used to increase access to off-site supervising [....] » Read More

Reza Chaman, Speaker at Oncology Conference
Oral Presentation
Reza Chaman, Yasuj University of Medical Sciences, Iran (Islamic Republic of)

Introduction: Breast cancer is the most common cancer among women worldwide with a rising incidence rate in most countries, due to the increased life expectancy, urbanization and lifestyle changes. This study was conducted to predict the breast cancer incidence trend among Irania [....] » Read More

S Nafees Bano, Speaker at Cancer Conferences
Oral Presentation
S Nafees Bano, HSZH Govt. Unani Medical College, India

Cancer is a leading cause of death worldwide. It strikes more than one third of the World’s population and it’s the cause of more than 20% of all deaths. Cancer is the uncontrolled growth of cells, which can invade and spread to distant sites of the body. Cancer can h [....] » Read More

Yousif Mohamed Yousif Abdallah, Speaker at Cancer Conferences
Oral Presentation
Yousif Mohamed Yousif Abdallah, Majmaah University, Saudi Arabia

Organ motion in Radiotherapy induces an error in dose received by the tumor therefore this experimental study conducted to evaluate the organs motion in external beam radiotherapy. This is an experimental study deals with detection, measurement and analysis of the periodic physio [....] » Read More

Yona Keisari, Speaker at 
Cancer Congress
Oral Presentation
Yona Keisari, Tel Aviv University, Israel

Introduction: Ablation strategies are non-surgical debulking procedures that can destroy solid tumors and release tumor antigens and damage associated molecular pattern molecules (DAMPs) for the induction of systemic anti-tumor immunity. Such anti-tumor immune responses can destr [....] » Read More

Watsapp